Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10695026 [patent_doc_number] => 20160041173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'METHODS AND ARRAYS FOR USE IN THE SAME' [patent_app_type] => utility [patent_app_number] => 14/781839 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19376 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 75 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781839 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/781839
Methods and arrays for use in the same Apr 1, 2014 Issued
Array ( [id] => 9772434 [patent_doc_number] => 20140296097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'MARKER FOR DETERMING EFFECTS OF ANTI-C-MET ANTIBODY AND METHOD OF DETERMING EFFECTS OF ANTI-C-MET ANTIBODY USING THE MARKER' [patent_app_type] => utility [patent_app_number] => 14/229073 [patent_app_country] => US [patent_app_date] => 2014-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17845 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14229073 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/229073
Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker Mar 27, 2014 Issued
Array ( [id] => 18203426 [patent_doc_number] => 11585815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Method for diagnosis of a benign renal oncocytoma by means of VIM3 [patent_app_type] => utility [patent_app_number] => 14/779536 [patent_app_country] => US [patent_app_date] => 2014-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8662 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779536 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/779536
Method for diagnosis of a benign renal oncocytoma by means of VIM3 Mar 24, 2014 Issued
Array ( [id] => 10960398 [patent_doc_number] => 20140363426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'HETERODIMERIC PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/216705 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 183 [patent_figures_cnt] => 183 [patent_no_of_words] => 37659 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14216705 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/216705
Heterodimeric proteins Mar 16, 2014 Issued
Array ( [id] => 10953360 [patent_doc_number] => 20140356381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'METHODS OF PURIFYING HETERODIMERIC PROTEINS USING IMMUNOGLOBULIN CLASS SWITCHING' [patent_app_type] => utility [patent_app_number] => 14/214418 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 33703 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214418 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/214418
Heterodimeric proteins Mar 13, 2014 Issued
Array ( [id] => 9771171 [patent_doc_number] => 20140294835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'NOVEL HETERODIMERIC PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/205227 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 30742 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205227 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/205227
NOVEL HETERODIMERIC PROTEINS Mar 10, 2014 Abandoned
Array ( [id] => 11612596 [patent_doc_number] => 09650446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-16 [patent_title] => 'Heterodimeric proteins' [patent_app_type] => utility [patent_app_number] => 14/205248 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 118 [patent_figures_cnt] => 118 [patent_no_of_words] => 40411 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205248 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/205248
Heterodimeric proteins Mar 10, 2014 Issued
Array ( [id] => 10679588 [patent_doc_number] => 20160025733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'METHODS OF DETECTING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/773599 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27265 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 60 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773599 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/773599
Methods of detecting prostate cancer Mar 6, 2014 Issued
Array ( [id] => 16743301 [patent_doc_number] => 10968276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Optimized anti-CD3 variable regions [patent_app_type] => utility [patent_app_number] => 14/200652 [patent_app_country] => US [patent_app_date] => 2014-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 113 [patent_no_of_words] => 27931 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200652 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/200652
Optimized anti-CD3 variable regions Mar 6, 2014 Issued
Array ( [id] => 10483323 [patent_doc_number] => 20150368342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/766105 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 26034 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766105 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/766105
CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF Feb 13, 2014 Abandoned
Array ( [id] => 9671617 [patent_doc_number] => 20140235479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/174072 [patent_app_country] => US [patent_app_date] => 2014-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35038 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174072 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/174072
SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF Feb 5, 2014 Abandoned
Array ( [id] => 10911752 [patent_doc_number] => 20140314770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'KIDNEY DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/173082 [patent_app_country] => US [patent_app_date] => 2014-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43019 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173082 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/173082
KIDNEY DISEASE TARGETS AND USES THEREOF Feb 4, 2014 Abandoned
Array ( [id] => 10642580 [patent_doc_number] => 09359437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Antibodies comprising chimeric constant domains' [patent_app_type] => utility [patent_app_number] => 14/170166 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 25305 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14170166 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/170166
Antibodies comprising chimeric constant domains Jan 30, 2014 Issued
Array ( [id] => 9537161 [patent_doc_number] => 20140161809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'DIAGNOSTIC AND THERAPEUTIC TARGET' [patent_app_type] => utility [patent_app_number] => 14/168907 [patent_app_country] => US [patent_app_date] => 2014-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8859 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168907 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/168907
DIAGNOSTIC AND THERAPEUTIC TARGET Jan 29, 2014 Abandoned
Array ( [id] => 9643139 [patent_doc_number] => 20140221252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'DETECTING NEOPLASM' [patent_app_type] => utility [patent_app_number] => 14/168552 [patent_app_country] => US [patent_app_date] => 2014-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15459 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168552 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/168552
Detecting neoplasm Jan 29, 2014 Issued
Array ( [id] => 9641944 [patent_doc_number] => 20140220056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 14/166939 [patent_app_country] => US [patent_app_date] => 2014-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14166939 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/166939
VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION Jan 28, 2014 Abandoned
Array ( [id] => 13067639 [patent_doc_number] => 10054596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Platelet biomarkers in cancer diagnosis [patent_app_type] => utility [patent_app_number] => 14/762394 [patent_app_country] => US [patent_app_date] => 2014-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25540 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762394 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/762394
Platelet biomarkers in cancer diagnosis Jan 21, 2014 Issued
Array ( [id] => 9656251 [patent_doc_number] => 20140227256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'Predictive biomarker for cancer treatment with ADCC-enhanced antibodies' [patent_app_type] => utility [patent_app_number] => 14/159895 [patent_app_country] => US [patent_app_date] => 2014-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19557 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159895 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/159895
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies Jan 20, 2014 Issued
Array ( [id] => 9602554 [patent_doc_number] => 20140199237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/158463 [patent_app_country] => US [patent_app_date] => 2014-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 24739 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14158463 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/158463
Methods and compositions for modulation of Olfml3 mediated angiogenisis Jan 16, 2014 Issued
Array ( [id] => 11737186 [patent_doc_number] => 09701759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Heterodimeric proteins' [patent_app_type] => utility [patent_app_number] => 14/155344 [patent_app_country] => US [patent_app_date] => 2014-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 104 [patent_no_of_words] => 31051 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14155344 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/155344
Heterodimeric proteins Jan 13, 2014 Issued
Menu